These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 18848554)

  • 1. Portal hypertension in primary biliary cirrhosis: a potentially reversible harbinger of demise.
    Mayo MJ
    Gastroenterology; 2008 Nov; 135(5):1450-1. PubMed ID: 18848554
    [No Abstract]   [Full Text] [Related]  

  • 2. Portal hypertension and primary biliary cirrhosis: effect of long-term ursodeoxycholic acid treatment.
    Huet PM; Vincent C; Deslaurier J; Coté J; Matsutami S; Boileau R; Huet-van Kerckvoorde J
    Gastroenterology; 2008 Nov; 135(5):1552-60. PubMed ID: 18722374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre.
    Floreani A; Caroli D; Variola A; Rizzotto ER; Antoniazzi S; Chiaramonte M; Cazzagon N; Brombin C; Salmaso L; Baldo V
    Liver Int; 2011 Mar; 31(3):361-8. PubMed ID: 21059170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Good prognosis in asymptomatic primary biliary cirrhosis].
    Lööf L; Lindgren S
    Lakartidningen; 2010 May 26-Jun 1; 107(21):1396-8. PubMed ID: 20645617
    [No Abstract]   [Full Text] [Related]  

  • 5. Reversal of portal hypertension in a patient with primary biliary cirrhosis: disappearance of esophageal varices and thrombocytopenia.
    El-Husseini R; Kaplan MM
    Am J Gastroenterol; 2004 Sep; 99(9):1859-60. PubMed ID: 15330929
    [No Abstract]   [Full Text] [Related]  

  • 6. Relatively high risk for hepatocellular carcinoma in patients with primary biliary cirrhosis not responding to ursodeoxycholic acid.
    Kuiper EM; Hansen BE; Adang RP; van Nieuwkerk CM; Timmer R; Drenth JP; Spoelstra P; Brouwer HT; Kuyvenhoven JP; van Buuren HR;
    Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1495-502. PubMed ID: 21389798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long-term beneficial effects of ursodeoxycholic acid in primary biliary cirrhosis are highly questionable.
    Yan G; Erik C; Gluud C
    Am J Gastroenterol; 2007 Feb; 102(2):464-5. PubMed ID: 17311669
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
    Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
    Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretransplant ursodeoxycholic acid therapy and liver transplantation in patients with primary biliary cirrhosis: win, win, win?
    Benner KG
    Liver Transpl Surg; 1999 Jul; 5(4):334-7. PubMed ID: 10388507
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients.
    ter Borg PC; Schalm SW; Hansen BE; van Buuren HR;
    Am J Gastroenterol; 2006 Sep; 101(9):2044-50. PubMed ID: 16848809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid.
    Kuiper EM; Hansen BE; de Vries RA; den Ouden-Muller JW; van Ditzhuijsen TJ; Haagsma EB; Houben MH; Witteman BJ; van Erpecum KJ; van Buuren HR;
    Gastroenterology; 2009 Apr; 136(4):1281-7. PubMed ID: 19208346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary biliary cirrhosis and CREST syndrome: a rare classical combination (literature review and case report)].
    Burnevich EZ; Ignatova TM
    Ter Arkh; 2000; 72(2):66-9. PubMed ID: 10717934
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years.
    Chan CW; Gunsar F; Feudjo M; Rigamonti C; Vlachogiannakos J; Carpenter JR; Burroughs AK
    Aliment Pharmacol Ther; 2005 Feb; 21(3):217-26. PubMed ID: 15691295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis.
    Lindor K
    N Engl J Med; 2007 Oct; 357(15):1524-9. PubMed ID: 17928600
    [No Abstract]   [Full Text] [Related]  

  • 15. [Primary biliary cirrhosis and ursodeoxycholic acid therapy].
    Makino I
    Nihon Naika Gakkai Zasshi; 1996 Mar; 85(3):399-403. PubMed ID: 8691003
    [No Abstract]   [Full Text] [Related]  

  • 16. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Chazouillères O; Wendum D; Serfaty L; Rosmorduc O; Poupon R
    J Hepatol; 2006 Feb; 44(2):400-6. PubMed ID: 16356577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis. Clinical and therapeutic analysis of 5 cases].
    Cheikh I; Said Y; Chaabouni H; Ouerghi H; Ben Ammar A
    Tunis Med; 2003 Jul; 81(7):499-504. PubMed ID: 14534962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic acid and long-term survival in primary biliary cirrhosis.
    Levy C; Angulo P
    Am J Gastroenterol; 2004 Feb; 99(2):269-70. PubMed ID: 15046216
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical epidemiology of primary biliary cirrhosis: incidence, prevalence, and impact of therapy.
    Lazaridis KN; Talwalkar JA
    J Clin Gastroenterol; 2007; 41(5):494-500. PubMed ID: 17450033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, prevalence and clinical course of primary biliary cirrhosis in a Spanish community.
    Pla X; Vergara M; Gil M; Dalmau B; Cisteró B; Bella RM; Real J
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):859-64. PubMed ID: 17873609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.